{"name":"KNOX PHARMACEUTICALS LIMITED","company_number":"03047023","status":"Active","type":"Private Limited Company","incorporated":"1995-04-18","dissolved":null,"registered_office":"Unit 2 Barugh Way, Barker Business Park,, Melmerby, Ripon, England, HG4 5NG","postcode":"HG4 5NG","sic_codes":[{"code":46460,"description":"Wholesale of pharmaceutical goods"}],"principal_activity":"The principal activity of the company continued to be that of the wholesale of pharmaceutical products.","previous_names":[],"warnings":[],"accounts":{"category":"Full","year_end":"31 October","last_made_up_to":"2025-10-31","next_due":"2027-07-31"},"employees":{"count":38,"accounts_date":"2025-10-31"},"financials":[{"financial_date":"2025-10-31","profit_loss":3826337,"net_assets":8581743,"cash":1963079,"average_employees":38},{"financial_date":"2024-10-31","profit_loss":3145544,"net_assets":5985406,"cash":1148269,"average_employees":39},{"financial_date":"2023-10-31","net_assets":6600962,"cash":2382064},{"financial_date":"2022-10-31","net_assets":5299778,"cash":1677824},{"financial_date":"2021-10-31","turnover":19312482,"net_assets":4553255,"cash":1491742}],"officers":{"current":2,"resigned":7,"complete":true,"note":"Names and details of individual officers are on the People page (subscriber-only on this site) and free at Companies House."},"charges":{"total":8,"outstanding":1},"gazette_notices":[],"insolvency_outcome":null,"ai_summary":"Knox Pharmaceuticals operates as a highly profitable, independent niche player within the UK pharmaceutical wholesale sector, achieving operating margins (13.9%) that vastly exceed the industry average for standard distribution models. Despite macroeconomic headwinds such as FX volatility and rising regulatory compliance costs, the company has delivered strong top-line growth of 11.3% to £30.26m, demonstrating robust pricing power and operational efficiency. However, the substantial dividend extraction of £3.76m and a growing debtors book highlight potential cash flow constraints that will require careful working capital management moving forward.","website":"https://www.knoxpharmaceuticals.com/","links":{"page":"https://www.companiesintheuk.co.uk/ltd/knox-pharmaceuticals","people":"https://www.companiesintheuk.co.uk/company/knox-pharmaceuticals/people","filing_history":"https://www.companiesintheuk.co.uk/company/knox-pharmaceuticals/filing-history","companies_house":"https://find-and-update.company-information.service.gov.uk/company/03047023","financials":"https://www.companiesintheuk.co.uk/company/knox-pharmaceuticals/financial","control":"https://www.companiesintheuk.co.uk/company/knox-pharmaceuticals/control","charges":"https://www.companiesintheuk.co.uk/company/knox-pharmaceuticals/charges","ai_analysis":"https://www.companiesintheuk.co.uk/company/knox-pharmaceuticals/analysis"},"source":"CompaniesInTheUK, from Companies House, The Gazette and other public registers (see /support/about). Cite as: CompaniesInTheUK, https://www.companiesintheuk.co.uk/ltd/knox-pharmaceuticals"}